I

Ishita Drugs and Industries Limited

ISHITADR
Market snapshot · 2026-08-10 21:11 UTC

72.30

₹-2.07 (-2.78%)

MARKET CAP

₹21.62 Cr

STOCK P/E

27.8x

52W HIGH

₹90.85

52W LOW

₹66.00

BOOK VALUE

₹38.47

EPS

₹2.60

ROE

6.96%

SECTOR

Healthcare

DEBT/EQUITY

0.71

VOLUME

4,447

P/B RATIO

1.88x

PEG RATIO

Sector

Healthcare

Themes

Drug Manufacturers - Specialty & Generic
₹83.00₹79.15₹75.30₹71.45₹67.60VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 1.0% below historical median. Valuation is stable — currently in the undervalued zone (z-score: -0.16). Confidence: 92%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Undervalued

5Y Average

25.40

Current

28.60

Overvalued

30.73

Undervalued

27.31

EV/EBITDA
Overvalued

5Y Average

18.67

Current

20.43

Overvalued

21.62

Undervalued

14.62

P/S
Overvalued

5Y Average

1.35

Current

1.47

Overvalued

1.55

Undervalued

1.15

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹3.15 CrJun 2026

Latest net profit

₹0.23 CrJun 2026

Latest EPS

₹0.77Jun 2026

Net margin

9.8%Jun 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.0%3.0%6.0%9.0%12.0%0.00 Cr2.00 Cr4.00 Cr6.00 Cr8.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.00 Cr2.00 Cr4.00 Cr6.00 Cr8.00 Cr₹0₹0₹1₹1₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr0.80 Cr1.60 Cr2.40 Cr3.20 Cr

Latest reported period: Jun 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-6.00 Cr0.00 Cr6.00 Cr12 Cr18 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales +3.094.403.214.503.033.274.134.565.403.073.143.063.15
Expenses +2.914.182.994.202.863.033.834.275.062.893.002.962.84
Operating Profit0.180.220.220.300.170.240.300.290.340.180.140.100.31
OPM %5.83%5.00%6.85%6.67%5.61%7.34%7.26%6.36%6.30%5.86%4.46%3.27%9.84%
Other Income +0.070.100.010.100.060.050.070.160.090.070.100.220.04
Interest0.030.010.040.020.010.000.020.040.020.000.020.020.00
Depreciation0.030.030.030.010.030.030.030.030.030.030.030.020.05
Profit before tax0.190.280.160.370.190.260.320.380.380.220.190.280.30
Tax %26.32%25.00%25.00%24.32%26.32%23.08%25.00%23.68%23.68%36.36%21.05%35.71%23.33%
Net Profit +0.140.210.120.280.150.190.240.290.300.140.160.180.23
EPS in Rs0.470.700.400.940.500.640.800.971.000.470.540.600.77
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +49.92%49.96%50.04%50.04%50.04%
Public +50.09%50.04%49.95%49.97%49.96%
Others0.01%
Jun 2026
Promoters +
Public +

Events Timeline

Announcement under Regulation 30 (LODR)-Change in Management

Aug 08, 2026PDFCompany Reports Open

Outcome Of Board Meeting Held On 08H August, 2026

Aug 08, 2026PDFCompany Reports Open

Board Meeting Outcome for Outcome Of Board Meeting Held On 08Th August, 2026

Aug 08, 2026PDFCompany Reports Open

Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 For The Quarter Ended 30Th June, 2026.

Jul 31, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 09, 2026PDFCompany Reports Open